Corcept Therapeutics
CORT
#2097
Rank
A$13.50 B
Marketcap
A$128.15
Share price
2.60%
Change (1 day)
38.94%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2025 (TTM): A$0.10 Billion

According to Corcept Therapeutics 's latest financial reports the company's current earnings are A$0.74 Billion. In 2024 the company made an earning of A$0.20 Billion, an increase over its 2023 earnings that were of A$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.10 B-50.37%
2024 A$0.20 B27.66%
2023 A$0.16 B-4.75%
2022 A$0.16 B-9.51%
2021 A$0.18 B-2.91%
2020 A$0.19 B14.87%
2019 A$0.16 B24.71%
2018 A$0.13 B69.32%
2017 A$79.39 M419.26%
2016 A$15.29 M-395.64%
2015 -A$5.18 Million-87.53%
2014 -A$41.5 Million-33.44%
2013 -A$62.34 Million
2011 -A$48.57 Million17.84%
2010 -A$41.22 Million35.5%
2009 -A$30.42 Million2.84%
2008 -A$29.58 Million60.81%
2007 -A$18.4 Million-52.14%
2006 -A$38.44 Million20.91%
2005 -A$31.79 Million31.87%
2004 -A$24.11 Million60.54%
2003 -A$15.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.66 B 49,305.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.06 B 12,150.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$24.66 B 24,939.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$33.80 B 34,218.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.80 B 17,974.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.68 B 35,113.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-A$41.23 Million-141.85%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$46.24 M-53.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$1.02 B 935.92%๐Ÿ‡บ๐Ÿ‡ธ USA